Get the Stockscreener App
3.31
4.42%
0.14
Park Ha Biological Technology Co Ltd stock is traded at $3.31, with a volume of 125.97K.
It is up +4.42% in the last 24 hours and up +719.31% over the past month.
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.
See More
Previous Close:
$3.17
Open:
$3.24
24h Volume:
125.97K
Relative Volume:
0.03
Market Cap:
$2.63M
Revenue:
$2.52M
Net Income/Loss:
$-24.36M
P/E Ratio:
-0.08
EPS:
-41.3755
Net Cash Flow:
$-2,900
1W Performance:
+5.41%
1M Performance:
+719.31%
6M Performance:
+8.17%
1Y Performance:
+0.00%
1-Day Range:
$3.16
$3.55
1-Week Range:
$3.01
$3.95
52-Week Range:
$0.32
$19.75
Park Ha Biological Technology Co Ltd Stock (BYAH) Company Profile
Name
Park Ha Biological Technology Co Ltd
Sector
Industry
Phone
-
Address
-
Compare BYAH vs PG, UL, CL, CCL, KVUE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BYAH
Park Ha Biological Technology Co Ltd
|
3.31 | 2.51M | 2.52M | -24.36M | -2,900 | -41.38 |
PG
Procter Gamble Co
|
144.55 | 334.90B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
62.09 | 132.90B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
91.95 | 73.59B | 20.80B | 2.22B | 3.77B | 2.5772 |
CCL
Colgate Palmolive Co
|
28.12 | 37.90B | 26.98B | 3.10B | 2.98B | 2.2492 |
KVUE
Kenvue Inc
|
19.20 | 36.46B | 15.29B | 1.62B | 1.82B | 0.8433 |
Park Ha Biological Technology Co Ltd Stock (BYAH) Latest News
ROSEN, RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. ... - Caledonian Record
Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) Stock Price, News & Analysis - Kalkine
Park Ha Biological Technology Lawsuit: PHH Investors Focus on Alleged Stock Promotion Scheme and 93% Drop - TipRanks
BYAH Deadline Alert: SueWallSt Reminds Park Ha Biological Technology Co. (BYAH) Investors of Securities Class Action Deadline on September 28, 2026 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming DeadlinesBYAH - PR Newswire
Stock splits calendar for: - Yahoo Finance UK
Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - WBOC TV
Lawsuit targets Park Ha Biotech insiders after stock plunges 93% in one day - Pluang
BYAH UPCOMING DEADLINE: Levi & Korsinsky Alerts Park Ha Biological Technology Co., Ltd. Stockholders of Securities Class ActionContact the Firm - PR Newswire
Park Ha Biological Technology Ord Shs (BYAH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit - PR Newswire
BYAH DEADLINE: The Gross Law Firm Reminds Park Ha Biological Technology Co., Ltd. Investors of Upcoming Securities Class Action Deadline - Morningstar
Robbins LLP Urges BYAH Stockholders Who Lost Money - GlobeNewswire
Park Ha Biological (BYAH) COO discloses 187,500 adjusted Class A shares - Stock Titan
BYAH DEADLINE: Levi & Korsinsky Reminds Park Ha Biological - GlobeNewswire
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
Stock Splits Calendar for: - Yahoo Finance
BYAH DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Park Ha Biological Technology Co., Ltd. Investors to Join the Class Action Lawsuit Today - ACCESS Newswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Park Ha Biological Technology Co., Ltd. Investors to ... - caledonianrecord.com
Park Ha Biological Technology (BYAH) Dips 2.48% to $3.14 as Key Support Comes into ViewOption Breadth - dars.gov.et
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 28, 2026 in Park Ha Biological Technology Co., Ltd. LawsuitBYAH - webull.com
CFO share grant at Park Ha Biological Technology (BYAH) after split - Stock Titan
BYAH SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Park Ha Biological Technology Co., Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
BYAH INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Park Ha Biological Technology Co., Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Did You Lose Money Investing in Park Ha Biological Technology Co., Ltd.? Robbins LLP Urges Investors to Contact the Firm for Information About Their Rights Against BYAH - TMX Newsfile
BYAH Shareholder Alert: Park Ha Biological Technology Co., Ltd. Securities Class Action LawsuitInvestors With Losses May Contact Levi & Korsinsky - Business Wire
Levi & Korsinsky Reminds Park Ha Biological Technology Co. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026BYAH - Morningstar
Park Ha Biological Technology Lawsuit Alleges Pump-and-Dump Scheme After 93% Stock Drop - TipRanks
Dividend HistoryPark Ha Biological Technology Co., Ltd. (BYAH) - Zacks Investment Research
BYAH STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Park Ha Biological Technology Co., Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Park Ha Biological Technology Sets August 6 Reverse Stock Split After Private Placement - TipRanks
Park Ha Biological Technology plans 1-for-8 reverse stock split effective Aug. 6 - Bitget
Park Ha Biological Technology Raises US$1.8 Million in August 3 Private Placement - TipRanks
BYAH: Park Ha Biological Technology Co., Ltd.Brokerage Recommendations Chart - Zacks Investment Research
BYAH SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Park Ha Biological Technology Co., Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DLT Resolution Inc. Secures Exclusive Rights to Bring Premium Korean Skincare Line to North America and Europe - Yahoo Finance
Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act - webull.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. ... - Caledonian Record
Park Ha Biological Technology (BYAH) Gains 5.17% to $0.37, Approaches Key $0.39 ResistanceRetail Driven Moves - dars.gov.et
BYAH INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Park Ha Biological Technology Co., Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Rosen Law Firm Urges Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
Class action lawsuit filed against Park Ha for alleged stock manipulation and misleading investors. - Pluang
Park Ha Biological Technology Co., Ltd. Revenue Breakdown – NASDAQ:BYAH - TradingView
Park Ha Biological Technology (BYAH) Faces Selling Pressure as Stock Tests Critical Support LevelsFade Trade - dars.gov.et
Park Ha Biological Technology Ord Shs (BYAH) Institutional Confidence - TradingKey
Park Ha Biological Technology Ord Shs (BYAH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Park Ha Biological Technology Files Form 6-K Reporting Slight Revenue Growth and Leaner Franchise Network - The Globe and Mail
Park Ha Biological Technology Co., Ltd. Reports Earnings Results for the Half Year Ended April 30, 2026 - marketscreener.com
Park Ha Biological Technology publishes MD&A for six months ended April 30, 2026 - Bitget
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Park Ha Biological Technology (BYAH) Stock Forum and Discussion - Moomoo
Park Ha Biological Technology Co Ltd Stock (BYAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):